(ATGE) Adtalem Global Education - Ratings and Ratios

Adtalem Global Education Inc. (NYSE:ATGE) is a leading provider of workforce solutions and education services worldwide. The company operates through three core segments: Chamberlain, Walden, and Medical and Veterinary. Chamberlain focuses on nursing and healthcare education, offering high-demand programs in nursing at the associate, bachelors, and graduate levels. Walden University specializes in online graduate and professional education, catering to working professionals in fields such as counseling, business, psychology, and public health. The Medical and Veterinary segment includes institutions like the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine, which provide medical and veterinary education to aspiring healthcare professionals. Adtalems programs are designed to bridge the gap between education and employment, emphasizing career-relevant skills in high-growth industries such as healthcare, technology, and business.

Formerly known as DeVry Education Group Inc., Adtalem Global Education Inc. rebranded in May 2017 to reflect its expanded focus on global workforce solutions and education. The company, incorporated in 1987 and headquartered in Chicago, Illinois, has established a strong presence in the education sector through its diverse portfolio of institutions. Adtalems commitment to innovation, accessibility, and outcomes-based education has positioned it as a key player in the global education market, with a focus on addressing the evolving needs of students and employers alike. For more information, visit https://www.adtalem.com.

3-Month Forecast (Using Technical and Fundamental Data): Based on the provided data, ATGE is trading above its 20-day and 50-day moving averages, indicating short-term bullish momentum. The stocks last price of $105.41 is above the SMA20 ($102.91) and SMA50 ($100.65), suggesting continued upward movement. However, the SMA200 ($87.52) remains below current levels, indicating longer-term support. The ATR of 4.66 suggests moderate volatility, which may lead to price fluctuations. Fundamentally, the forward P/E of 14.73 indicates potential undervaluation relative to future earnings, while the RoE of 14.47% highlights strong profitability. Over the next three months, ATGE is expected to maintain its uptrend, with potential pullbacks supported by the SMA50 level. The stock may face resistance near $110, with upside driven by improving earnings expectations and sector tailwinds in education services.